Why is Caplin Point Lab falling/rising?

As of 21-Aug, Caplin Point Laboratories Ltd is experiencing a price increase, currently at Rs 2,205.00, reflecting a rise of 100.95 (4.8%). Today's performance indicates that the stock has outperformed its sector by 4.34% and has shown a trend reversal after two consecutive days of decline. The stock reached an intraday high of Rs 2,222, marking a 5.61% increase. Over the past week, Caplin Point has gained 3.74%, and over the last month, it has increased by 5.12%. The company has demonstrated strong financial performance, with positive results for the last 12 consecutive quarters, including record net sales and profit after tax. Additionally, the increasing participation of institutional investors, who have raised their stake by 0.65%, suggests growing confidence in the company's fundamentals.
In the broader market context, Caplin Point's short-term return of 3.74% over the past week significantly outpaces the Sensex's increase of 1.74% during the same period. While the stock has shown strong performance in the short term, it has faced challenges year-to-date, with a decline of 11.86% compared to the Sensex's gain of 4.94%. Despite this, the stock's consistent returns over the past three years, including a 25.78% increase in the last year, highlight its resilience and ability to outperform the broader market in the long run. The company's low debt-to-equity ratio and high management efficiency further support its positive outlook, contributing to the recent rise in stock price.